COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.
Identifieur interne : 000098 ( Main/Exploration ); précédent : 000097; suivant : 000099COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.
Auteurs : Lauren Caton [États-Unis] ; Hannah Cheng [États-Unis] ; Hélène Chokron Garneau [États-Unis] ; Tammy Fisher [États-Unis] ; Briana Harris-Mills [États-Unis] ; Brian Hurley [États-Unis] ; Sandra Newman [États-Unis] ; Mark P. Mcgovern [États-Unis]Source :
- Journal of general internal medicine [ 1525-1497 ] ; 2021.
Abstract
BACKGROUND
With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care.
OBJECTIVE
To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19.
DESIGN
A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days.
PARTICIPANTS
We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey.
MAIN MEASURES
The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience.
KEY RESULTS
A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care.
CONCLUSIONS
Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.
DOI: 10.1007/s11606-020-06436-3
PubMed: 33511572
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.</title><author><name sortKey="Caton, Lauren" sort="Caton, Lauren" uniqKey="Caton L" first="Lauren" last="Caton">Lauren Caton</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Cheng, Hannah" sort="Cheng, Hannah" uniqKey="Cheng H" first="Hannah" last="Cheng">Hannah Cheng</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Garneau, Helene Chokron" sort="Garneau, Helene Chokron" uniqKey="Garneau H" first="Hélène Chokron" last="Garneau">Hélène Chokron Garneau</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Fisher, Tammy" sort="Fisher, Tammy" uniqKey="Fisher T" first="Tammy" last="Fisher">Tammy Fisher</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Harris Mills, Briana" sort="Harris Mills, Briana" uniqKey="Harris Mills B" first="Briana" last="Harris-Mills">Briana Harris-Mills</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Hurley, Brian" sort="Hurley, Brian" uniqKey="Hurley B" first="Brian" last="Hurley">Brian Hurley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Family Medicine, University of California Los Angeles, Los Angeles, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Los Angeles County Department of Health Services, Los Angeles, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Los Angeles County Department of Health Services, Los Angeles, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Newman, Sandra" sort="Newman, Sandra" uniqKey="Newman S" first="Sandra" last="Newman">Sandra Newman</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Mcgovern, Mark P" sort="Mcgovern, Mark P" uniqKey="Mcgovern M" first="Mark P" last="Mcgovern">Mark P. Mcgovern</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA. mpmcg@stanford.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mpmcg@stanford.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:33511572</idno><idno type="pmid">33511572</idno><idno type="doi">10.1007/s11606-020-06436-3</idno><idno type="wicri:Area/Main/Corpus">000000</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000000</idno><idno type="wicri:Area/Main/Curation">000000</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000000</idno><idno type="wicri:Area/Main/Exploration">000000</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.</title><author><name sortKey="Caton, Lauren" sort="Caton, Lauren" uniqKey="Caton L" first="Lauren" last="Caton">Lauren Caton</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Cheng, Hannah" sort="Cheng, Hannah" uniqKey="Cheng H" first="Hannah" last="Cheng">Hannah Cheng</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Garneau, Helene Chokron" sort="Garneau, Helene Chokron" uniqKey="Garneau H" first="Hélène Chokron" last="Garneau">Hélène Chokron Garneau</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Fisher, Tammy" sort="Fisher, Tammy" uniqKey="Fisher T" first="Tammy" last="Fisher">Tammy Fisher</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Harris Mills, Briana" sort="Harris Mills, Briana" uniqKey="Harris Mills B" first="Briana" last="Harris-Mills">Briana Harris-Mills</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Hurley, Brian" sort="Hurley, Brian" uniqKey="Hurley B" first="Brian" last="Hurley">Brian Hurley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Family Medicine, University of California Los Angeles, Los Angeles, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Los Angeles County Department of Health Services, Los Angeles, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Los Angeles County Department of Health Services, Los Angeles, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Newman, Sandra" sort="Newman, Sandra" uniqKey="Newman S" first="Sandra" last="Newman">Sandra Newman</name><affiliation wicri:level="2"><nlm:affiliation>Center for Care Innovations, Oakland, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Care Innovations, Oakland, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Mcgovern, Mark P" sort="Mcgovern, Mark P" uniqKey="Mcgovern M" first="Mark P" last="Mcgovern">Mark P. Mcgovern</name><affiliation wicri:level="2"><nlm:affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA. mpmcg@stanford.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mpmcg@stanford.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><series><title level="j">Journal of general internal medicine</title><idno type="eISSN">1525-1497</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19.</p></div><div type="abstract" xml:lang="en"><p><b>DESIGN</b></p><p>A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days.</p></div><div type="abstract" xml:lang="en"><p><b>PARTICIPANTS</b></p><p>We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey.</p></div><div type="abstract" xml:lang="en"><p><b>MAIN MEASURES</b></p><p>The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience.</p></div><div type="abstract" xml:lang="en"><p><b>KEY RESULTS</b></p><p>A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33511572</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1497</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of general internal medicine</Title><ISOAbbreviation>J Gen Intern Med</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11606-020-06436-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey.</AbstractText><AbstractText Label="MAIN MEASURES" NlmCategory="METHODS">The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience.</AbstractText><AbstractText Label="KEY RESULTS" NlmCategory="RESULTS">A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caton</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garneau</LastName><ForeName>Hélène Chokron</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Tammy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Care Innovations, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris-Mills</LastName><ForeName>Briana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Care Innovations, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurley</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Los Angeles County Department of Health Services, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Care Innovations, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGovern</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9736-573X</Identifier><AffiliationInfo><Affiliation>Center for Behavioral Health Services and Implementation Research, Division of Public Mental Health and Population Sciences, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA. mpmcg@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mpmcg@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>18-95529</GrantID><Agency>California Department of Health and Health Care Services</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gen Intern Med</MedlineTA><NlmUniqueID>8605834</NlmUniqueID><ISSNLinking>0884-8734</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">medications for opioid use disorder (MOUD)</Keyword><Keyword MajorTopicYN="N">office-based opioid treatment (OBOT)</Keyword><Keyword MajorTopicYN="N">opioid use disorder (OUD)</Keyword><Keyword MajorTopicYN="N">telehealth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33511572</ArticleId><ArticleId IdType="doi">10.1007/s11606-020-06436-3</ArticleId><ArticleId IdType="pii">10.1007/s11606-020-06436-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic. New England Journal of Medicine. 2014;370(22):2063–2066. https://doi.org/10.1056/NEJMp1402780 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1402780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews. 2016;2016(5). https://doi.org/10.1002/14651858.CD011117.pub2 .</Citation></Reference><Reference><Citation>Doernberg M, Krawczyk N, Agus D, Fingerhood M. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis? Substance Abuse. 2019;40(2):148–153. https://doi.org/10.1080/08897077.2019.1572052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08897077.2019.1572052</ArticleId><ArticleId IdType="pubmed">31008694</ArticleId><ArticleId IdType="pmcid">6800751</ArticleId></ArticleIdList></Reference><Reference><Citation>Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment. 2017;78:1–7. https://doi.org/10.1016/j.jsat.2017.04.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsat.2017.04.005</ArticleId><ArticleId IdType="pubmed">28554597</ArticleId><ArticleId IdType="pmcid">5524453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson E, Catlin M, Andrilla CHA, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Annals of Family Medicine. 2014;12(2):128–133. https://doi.org/10.1370/afm.1595 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1595</ArticleId><ArticleId IdType="pubmed">24615308</ArticleId><ArticleId IdType="pmcid">3948759</ArticleId></ArticleIdList></Reference><Reference><Citation>Samet JH, Botticelli M, Bharel M. Methadone in primary care - one small step for congress, one giant leap for addiction treatment. New England Journal of Medicine. 2018;379(1):7–8. https://doi.org/10.1056/NEJMp1803982 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1803982</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffajee RL, Bohnert ASB, Lagisetty PA. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. American Journal of Preventive Medicine. 2018;54(6):S230-S242. https://doi.org/10.1016/j.amepre.2017.12.022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2017.12.022</ArticleId><ArticleId IdType="pubmed">29779547</ArticleId><ArticleId IdType="pmcid">6330240</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiscella K, Wakeman SE, Beletsky L. Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver. JAMA Psychiatry. 2019;76(3):229–230. https://doi.org/10.1001/jamapsychiatry.2018.3685 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2018.3685</ArticleId><ArticleId IdType="pubmed">30586140</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis CS, Carr DH. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States. International Journal of Drug Policy. 2019;73:42–48. https://doi.org/10.1016/j.drugpo.2019.07.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugpo.2019.07.006</ArticleId><ArticleId IdType="pubmed">31336293</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins Coronavirus Resource Center. COVID-19 United States Cases by County. https://coronavirus.jhu.edu/us-map . Accessed 6 Oct 2020.</Citation></Reference><Reference><Citation>Johns Hopkins Coronavirus Resource Center. Impact of Opening and Closing Decisions by States. https://coronavirus.jhu.edu/data/state-timeline . Accessed 6 Oct 2020.</Citation></Reference><Reference><Citation>Dunlop A, Lokuge B, Masters D, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm reduction journal. 2020;17(1):26–26. https://doi.org/10.1186/s12954-020-00370-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12954-020-00370-7</ArticleId><ArticleId IdType="pubmed">32375887</ArticleId><ArticleId IdType="pmcid">7201394</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AR, Samples H, Crystal S, Olfson M. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder. Am J Psychiatry. 2020;177(2):117–124. https://doi.org/10.1176/appi.ajp.2019.19060612 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2019.19060612</ArticleId><ArticleId IdType="pubmed">31786933</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Enforcement Administration. COVID-19 Information Page. Diversion Control Division. https://www.deadiversion.usdoj.gov/coronavirus.html . Accessed 15 Jul 2020.</Citation></Reference><Reference><Citation>Department of Justice, United States. Use of Telemedicine While Providing Medication Assisted Treatment (MAT).; 2018.</Citation></Reference><Reference><Citation>Substance Abuse and Mental Health Services Administration. Opioid Treatment Program (OTP) Guidance. www.samhsa.gov . Accessed 15 Jul 2020.</Citation></Reference><Reference><Citation>Substance Abuse and Mental Health Services Administration. FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency. https://www.samhsa.gov/sites/default/files/otp-guidance-20200316.pdf . Accessed 15 Jul 2020.</Citation></Reference><Reference><Citation>U.S. Department of Health & Human Services, Office for Civil Rights. Notification of Enforcement Discretion for Telehealth. Health Information Privacy. Published March 30, 2020. https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/notification-enforcement-discretion-telehealth/index.html . Accessed 15 Jul 2020.</Citation></Reference><Reference><Citation>Vecchio S, Ramella R, Drago A, Carraro D, Littlewood R, Somaini L. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research. 2020;289. https://doi.org/10.1016/j.psychres.2020.113047 .</Citation></Reference><Reference><Citation>Marsden J, Darke S, Hall W, et al. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction. 2020;115(6). https://doi.org/10.1111/add.15080 .</Citation></Reference><Reference><Citation>Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Substance Abuse. 2020;41(2):147–149. https://doi.org/10.1080/08897077.2020.1752351 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08897077.2020.1752351</ArticleId><ArticleId IdType="pubmed">32314951</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis CS, Samuels EA. Opioid Policy Changes During the COVID-19 Pandemic - and Beyond. Journal of addiction medicine. Published online 2020. https://doi.org/10.1097/ADM.0000000000000679 .</Citation></Reference><Reference><Citation>Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4–23. https://doi.org/10.1007/s10488-010-0327-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10488-010-0327-7</ArticleId><ArticleId IdType="pubmed">21197565</ArticleId></ArticleIdList></Reference><Reference><Citation>McGovern MP, Hurley B, Fisher T, Caton L. Primary Care Practice Adaptations for Patients with Opioid Use Disorder during COVID-19: A Survey.</Citation></Reference><Reference><Citation>Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their Repair. Annual Review of Clinical Psychology. 2014;10(1):641–677. https://doi.org/10.1146/annurev-clinpsy-032813-153724 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-clinpsy-032813-153724</ArticleId><ArticleId IdType="pubmed">24679180</ArticleId><ArticleId IdType="pmcid">4501268</ArticleId></ArticleIdList></Reference><Reference><Citation>Oser CB, Biebel EP, Pullen E, Harp KL. Causes, Consequences, and Prevention of Burnout among Substance Abuse Treatment Counselors: A Rural versus Urban Comparison. J Psychoactive Drugs. 2013;45(1):17–27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02791072.2013.763558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenheimer T, Sinsky C. From triple to Quadruple Aim: Care of the patient requires care of the provider. Annals of Family Medicine. 2014;12(6):573–576. https://doi.org/10.1370/afm.1713 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1713</ArticleId><ArticleId IdType="pubmed">25384822</ArticleId><ArticleId IdType="pmcid">4226781</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YT, Weintraub E, Haffajee RL. Telemedicine’s Role in Addressing the Opioid Epidemic. Mayo Clin Proc. 2018;93(9):1177–1180. https://doi.org/10.1016/j.mayocp.2018.07.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.07.001</ArticleId><ArticleId IdType="pubmed">30097301</ArticleId><ArticleId IdType="pmcid">6330237</ArticleId></ArticleIdList></Reference><Reference><Citation>McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation. JAMA. 2000;284(13):1689–1695. https://doi.org/10.1001/jama.284.13.1689 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.284.13.1689</ArticleId><ArticleId IdType="pubmed">11015800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Caton, Lauren" sort="Caton, Lauren" uniqKey="Caton L" first="Lauren" last="Caton">Lauren Caton</name></region><name sortKey="Cheng, Hannah" sort="Cheng, Hannah" uniqKey="Cheng H" first="Hannah" last="Cheng">Hannah Cheng</name><name sortKey="Fisher, Tammy" sort="Fisher, Tammy" uniqKey="Fisher T" first="Tammy" last="Fisher">Tammy Fisher</name><name sortKey="Garneau, Helene Chokron" sort="Garneau, Helene Chokron" uniqKey="Garneau H" first="Hélène Chokron" last="Garneau">Hélène Chokron Garneau</name><name sortKey="Harris Mills, Briana" sort="Harris Mills, Briana" uniqKey="Harris Mills B" first="Briana" last="Harris-Mills">Briana Harris-Mills</name><name sortKey="Hurley, Brian" sort="Hurley, Brian" uniqKey="Hurley B" first="Brian" last="Hurley">Brian Hurley</name><name sortKey="Hurley, Brian" sort="Hurley, Brian" uniqKey="Hurley B" first="Brian" last="Hurley">Brian Hurley</name><name sortKey="Mcgovern, Mark P" sort="Mcgovern, Mark P" uniqKey="Mcgovern M" first="Mark P" last="Mcgovern">Mark P. Mcgovern</name><name sortKey="Mcgovern, Mark P" sort="Mcgovern, Mark P" uniqKey="Mcgovern M" first="Mark P" last="Mcgovern">Mark P. Mcgovern</name><name sortKey="Newman, Sandra" sort="Newman, Sandra" uniqKey="Newman S" first="Sandra" last="Newman">Sandra Newman</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000098 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000098 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidStanfordV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33511572
|texte= COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33511572" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidStanfordV1
| This area was generated with Dilib version V0.6.38. |  |